Tetsuya Abe1,2, Masaki Takao1,3, Hiroaki Kimura3, Kazunori Akaji4, Ban Mihara3, Norio Tanahashi1, Takashi Kanda2. 1. Department of Neurology, Saitama Medical University International Medical Center, Hidaka, Japan. 2. Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan. 3. Department of Neurology, Mihara Memorial Hospital, Isesaki, Japan. 4. Department of Neurosurgery, Mihara Memorial Hospital, Isesaki, Japan.
Abstract
INTRODUCTION: Compared with 1.5T magnetic resonance imaging (MRI), using 3.0T MRI makes it easier to detect cerebral microbleeds (CMBs). We used 3.0T MRI to investigate the backgrounds, risk factors, and number and location of CMBs in patients with ischemic or hemorrhagic stroke. METHODS: We extracted data on clinical characteristics, risk factors, and number and location of CMBs in 2,003 patients treated between January 2010 and December 2014 within one week of stroke occurrence. We then carried out multivariate analysis of the data. RESULTS: CMBs were present in 1,025 patients. The numbers of CMBs in ischemic stroke and hemorrhagic stroke patients were 9,410 and 6,419, respectively. Patients with CMBs showed significantly higher rates of cognitive impairment (p < 0.001, odds ratio [OR] = 1.514), hypertension (p < 0.001, OR = 3.145), previous history of stroke (p < 0.001, OR = 1.782), and presence of hemorrhagic stroke (p < 0.001, OR = 2.066). The use of antithrombotic medication before the stroke did not affect the incidence of CMBs. In ischemic stroke patients, patients with small vessel occlusion had a significantly greater rate of previous history of hemorrhagic stroke (p = 0.046) and number of patients with CMBs (p < 0.001) than those with cardioembolism. CONCLUSIONS: CMBs were well observed in patients with small vessel disease, and hypertension was an important factor in ischemic and hemorrhagic stroke. Antithrombotic medication is not associated with the development of CMBs if adequate antihypertensive therapy is provided.
INTRODUCTION: Compared with 1.5T magnetic resonance imaging (MRI), using 3.0T MRI makes it easier to detect cerebral microbleeds (CMBs). We used 3.0T MRI to investigate the backgrounds, risk factors, and number and location of CMBs in patients with ischemic or hemorrhagic stroke. METHODS: We extracted data on clinical characteristics, risk factors, and number and location of CMBs in 2,003 patients treated between January 2010 and December 2014 within one week of stroke occurrence. We then carried out multivariate analysis of the data. RESULTS: CMBs were present in 1,025 patients. The numbers of CMBs in ischemic stroke and hemorrhagic stroke patients were 9,410 and 6,419, respectively. Patients with CMBs showed significantly higher rates of cognitive impairment (p < 0.001, odds ratio [OR] = 1.514), hypertension (p < 0.001, OR = 3.145), previous history of stroke (p < 0.001, OR = 1.782), and presence of hemorrhagic stroke (p < 0.001, OR = 2.066). The use of antithrombotic medication before the stroke did not affect the incidence of CMBs. In ischemic stroke patients, patients with small vessel occlusion had a significantly greater rate of previous history of hemorrhagic stroke (p = 0.046) and number of patients with CMBs (p < 0.001) than those with cardioembolism. CONCLUSIONS: CMBs were well observed in patients with small vessel disease, and hypertension was an important factor in ischemic and hemorrhagic stroke. Antithrombotic medication is not associated with the development of CMBs if adequate antihypertensive therapy is provided.
Authors: Mariëlle M F Poels; Meike W Vernooij; M Arfan Ikram; Albert Hofman; Gabriel P Krestin; Aad van der Lugt; Monique M B Breteler Journal: Stroke Date: 2010-10 Impact factor: 7.914
Authors: Ah-Ling Cheng; Saima Batool; Cheryl R McCreary; M L Lauzon; Richard Frayne; Mayank Goyal; Eric E Smith Journal: Stroke Date: 2013-08-06 Impact factor: 7.914
Authors: S M Gregoire; H R Jäger; T A Yousry; C Kallis; M M Brown; D J Werring Journal: J Neurol Neurosurg Psychiatry Date: 2010-06 Impact factor: 10.154
Authors: Nicholas M Gregg; Albert E Kim; M Edip Gurol; Oscar L Lopez; Howard J Aizenstein; Julie C Price; Chester A Mathis; Jeffrey A James; Beth E Snitz; Ann D Cohen; M Ilyas Kamboh; Davneet Minhas; Lisa A Weissfeld; Erica L Tamburo; William E Klunk Journal: JAMA Neurol Date: 2015-09 Impact factor: 18.302
Authors: Yannie O Y Soo; Song Ran Yang; Wynnie W M Lam; Adrian Wong; Yu Hua Fan; Howan H W Leung; Anne Y Y Chan; Cecilia Leung; Thomas W H Leung; Lawrence K S Wong Journal: J Neurol Date: 2008-12-08 Impact factor: 4.849